Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Jiahui Cai

Ping Dong

Xiongxiong He

Xiquan Zhang

Xifeng Lu

Zhenxue Deng

Xin Huang

Shanshan Sui

Jiao Xu

Bo Jiang

A pharmaceutical composition comprising dabigatran etexilate, and preparation method and use thereof, and solid preparation comprising the pharmaceutical composition; the pharmaceutical composition comprises a vitamin C layer and a dabigatran etexilate layer separated by a semipermeable film layer, and the semipermeable film layer comprises a water-soluble compound, a water-insoluble compound and an optional anti-sticking agent and/or plasticizer.

Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof

The present application provides a pharmaceutical composition comprising 6-(2-chloro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-methyl-4-oxo-4,5-dihydrofuro[3,2-c]pyridine-7-carboxamide or a pharmaceutically acceptable salt, a binder, a surface stabilizer and a dispersant, wherein the pharmaceutical composition can be dispersed in water to form a pharmaceutical suspension having a median particle size, X50, of 0.5 &#x3bc;m to 4.0 &#x3bc;m. Also disclosed are a preparation method thereof and the use thereof for treating cancers.

Pharmaceutical composition of MEK inhibitor and preparation method thereof

Growing community of inventors

Lianyungang, China

Jiahui Cai